Annual Current Liabilities
$18.46 M
+$7.55 M+69.12%
31 December 2023
Summary:
INmune Bio annual total current liabilities is currently $18.46 million, with the most recent change of +$7.55 million (+69.12%) on 31 December 2023. During the last 3 years, it has risen by +$16.69 million (+939.70%). INMB annual current liabilities is now at all-time high.INMB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$13.82 M
-$1.23 M-8.16%
30 September 2024
Summary:
INmune Bio quarterly total current liabilities is currently $13.82 million, with the most recent change of -$1.23 million (-8.16%) on 30 September 2024. Over the past year, it has dropped by -$533.00 thousand (-3.71%). INMB quarterly current liabilities is now -25.14% below its all-time high of $18.46 million, reached on 31 December 2023.INMB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INMB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.1% | -3.7% |
| 3 y3 years | +939.7% | +187.4% |
| 5 y5 years | +2141.4% | +2581.5% |
INMB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +939.7% | -25.1% | +504.9% |
| 5 y | 5 years | at high | +2536.3% | -25.1% | +2581.5% |
| alltime | all time | at high | +5862.2% | -25.1% | +6438.8% |
INmune Bio Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.82 M(-8.2%) |
| June 2024 | - | $15.05 M(-13.7%) |
| Mar 2024 | - | $17.45 M(-5.5%) |
| Dec 2023 | $18.46 M(+69.1%) | $18.46 M(+28.6%) |
| Sept 2023 | - | $14.36 M(+10.0%) |
| June 2023 | - | $13.05 M(+27.0%) |
| Mar 2023 | - | $10.28 M(-5.8%) |
| Dec 2022 | $10.92 M(+150.5%) | $10.92 M(+58.3%) |
| Sept 2022 | - | $6.89 M(+201.8%) |
| June 2022 | - | $2.29 M(-29.2%) |
| Mar 2022 | - | $3.23 M(-26.0%) |
| Dec 2021 | $4.36 M | $4.36 M(-9.4%) |
| Sept 2021 | - | $4.81 M(+60.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $2.99 M(+36.1%) |
| Mar 2021 | - | $2.20 M(+23.6%) |
| Dec 2020 | $1.78 M(+153.6%) | $1.78 M(+20.5%) |
| Sept 2020 | - | $1.47 M(+21.1%) |
| June 2020 | - | $1.22 M(+9.0%) |
| Mar 2020 | - | $1.12 M(+59.5%) |
| Dec 2019 | $700.40 K(-15.0%) | $700.40 K(+35.9%) |
| Sept 2019 | - | $515.50 K(-0.0%) |
| June 2019 | - | $515.60 K(-34.0%) |
| Mar 2019 | - | $780.90 K(-5.2%) |
| Dec 2018 | $823.80 K(+166.0%) | $823.80 K(+289.7%) |
| Sept 2018 | - | $211.40 K(-31.7%) |
| Dec 2017 | $309.70 K(-48.5%) | $309.70 K |
| Dec 2016 | $600.80 K | - |
FAQ
- What is INmune Bio annual total current liabilities?
- What is the all time high annual current liabilities for INmune Bio?
- What is INmune Bio annual current liabilities year-on-year change?
- What is INmune Bio quarterly total current liabilities?
- What is the all time high quarterly current liabilities for INmune Bio?
- What is INmune Bio quarterly current liabilities year-on-year change?
What is INmune Bio annual total current liabilities?
The current annual current liabilities of INMB is $18.46 M
What is the all time high annual current liabilities for INmune Bio?
INmune Bio all-time high annual total current liabilities is $18.46 M
What is INmune Bio annual current liabilities year-on-year change?
Over the past year, INMB annual total current liabilities has changed by +$7.55 M (+69.12%)
What is INmune Bio quarterly total current liabilities?
The current quarterly current liabilities of INMB is $13.82 M
What is the all time high quarterly current liabilities for INmune Bio?
INmune Bio all-time high quarterly total current liabilities is $18.46 M
What is INmune Bio quarterly current liabilities year-on-year change?
Over the past year, INMB quarterly total current liabilities has changed by -$533.00 K (-3.71%)